Regenxbio director Gregory Austin Ciongoli acquires common shares worth $952,001.59

Reuters2026/08/27 23:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Regenxbio director Gregory Austin Ciongoli lifted his stake to 118,035 common shares, reflecting open-market buying.
Purchases totaled 102,603 shares at weighted-average prices of USD 9.14, USD 9.36.
He also received 15,432 restricted stock units.
Award included 69,609 stock options with an exercise price of USD 8.91.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenxbio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002023732-26-000008), on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Regenxbio director Gregory Austin Ciongoli acquires common shares worth $952,001.59

You may also like

Crypto prices